The trials completed are substantial. IMO the real value will be in inflammatory bowel disease ,dermatology ,P53 modulation in cancer and other indications.
Funding through partnerships and/or licensing agreements will be key to unlocking the value.
I have never been more optimistic about my investment in IPIX and I am thankful I have been able to secure my investment at such a bargain price.
News 
Market Data 
Discover 
AI
